JFL
AVNS

Jarislowsky, Fraser Ltd’s Avanos Medical AVNS Stock Holding History

Jarislowsky, Fraser Ltd’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,556
Closed -$201K – 215
2018
Q3 		$201K Sell
3,556
-658
-16% -$42.3K ﹤0.01% 202
2018
Q2 		$241K Buy
+4,214
New +$223K ﹤0.01% 204
2018
Q1 		– Sell
-4,398
Closed -$203K – 218
2017
Q4 		$203K Sell
4,398
-62
-1% -$2.85K ﹤0.01% 223
2017
Q3 		$200K Buy
+4,460
New +$190K ﹤0.01% 222
2017
Q1 		– Sell
-6,585
Closed -$243K – 200
2016
Q4 		$243K Buy
+6,585
New +$235K ﹤0.01% 185

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jarislowsky, Fraser Ltd's AVNS Position: Q4 2018 in Review

Jarislowsky, Fraser Ltd sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 3,556 shares — an estimated $201K sold.

Jarislowsky, Fraser Ltd first reported a position in AVNS in Q4 2016 and held it in 5 quarters. The position peaked at $243K in Q4 2016. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Jarislowsky, Fraser Ltd reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Jarislowsky, Fraser Ltd sold 3,556 Avanos Medical shares in Q4 2018, an estimated $201K.
  • Jarislowsky, Fraser Ltd first reported a position in Avanos Medical in Q4 2016 and held it in 5 quarters.
  • Jarislowsky, Fraser Ltd's Avanos Medical position peaked at $243K in Q4 2016.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q4 2018, filed 1 Feb 2019.